Skip to main content
. 2017 Mar 14;8(20):32706–32721. doi: 10.18632/oncotarget.16188

Figure 3. Effect of Carbenoxolone on s.c. tumors growth and HMGB1 and CD31 levels.

Figure 3

(A) Tumors started developing 8 days post LLC cells s.c. injections in C57BL/6 mice. Treatment administered on the 10th day- 50 mg/kg i.p., with PBS as control, q.o.d. Tumor volume was measured using a caliper. End point was on the 17th day and tumors were harvested. (B, C) Weight and volume of tumors post resection. (D) Representative figures of tumor sections stained for HMGB1 and CD31. n = 8. ns = non significant.